Hepatitis B viral kinetics: a dynamic puzzle still to be resolved.
Neumann
Avidan U
AU
Faculty of Life Sciences, University of Bar-Ilan, Ramat-Gan 52900, Israel. neumann@mail.biu.ac.il
D000998:Antiviral Agents / Q000627:therapeutic use*; D004279:DNA, Viral / Q000032:analysis; D004359:Drug Therapy, Combination; D006509:Hepatitis B / Q000188:drug therapy / Q000821:virology*; D006513:Hepatitis B e Antigens / Q000097:blood; D006515:Hepatitis B virus / Q000302:isolation & purification*; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use; D007700:Kinetics; D011092:Polyethylene Glycols / Q000627:therapeutic use; D011994:Recombinant Proteins
D000998:Antiviral Agents; D004279:DNA, Viral; D006513:Hepatitis B e Antigens; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D011092:Polyethylene Glycols; C100416:peginterferon alfa-2a